Den Europæiske Union - dansk - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - carmustin - hodgkin disease; lymphoma, non-hodgkin - antineoplastiske midler - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 og 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - docetaxel - koncentrat til infusionsvæske, opløsning - 20 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

fresenius kabi ab - ertapenemnatrium - pulver til koncentrat til infusionsvæske, opløsning - 1 g

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

laboratorio reig jofre s.a. - pemetrexeddinatrium - pulver til koncentrat til infusionsvæske, opløsning - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

laboratorio reig jofre s.a. - pemetrexeddinatrium - pulver til koncentrat til infusionsvæske, opløsning - 500 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

intas pharmaceuticals limited - bendamustinhydrochlorid - pulver til koncentrat til infusionsvæske, opløsning - 2,5 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - oxaliplatin - koncentrat til infusionsvæske, opløsning - 5 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - Æblesyre, calciumchloriddihydrat, hydroxyethylstivelse, kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid - infusionsvæske, opløsning - 60 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - cytarabin - injektions-/infusionsvæske, opløsning - 20 mg/ml